Evidence map›Paper›PMID 35360235›Full record

ArticleFrontiers in physiology2022

Physiological Network Is Disrupted in Severe COVID-19.

Antonio Barajas-Martínez, Roopa Mehta, Elizabeth Ibarra-Coronado, Ruben Fossion, Vania J Martínez Garcés, Monserrat Ramírez Arellano, Ibar A González Alvarez, Yamilet Viana Moncada Bautista, Omar Y Bello-Chavolla, Natalia Ramírez Pedraza and 14 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 1 country.

Antonio Barajas-MartínezCentro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Roopa MehtaUnidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Elizabeth Ibarra-CoronadoInstituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Ruben FossionCentro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Vania J Martínez GarcésFacultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Monserrat Ramírez ArellanoFacultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Ibar A González AlvarezFacultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Yamilet Viana Moncada BautistaFacultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Omar Y Bello-ChavollaDivisión de Investigación, Instituto Nacional de Geriatría, Ciudad de México, Mexico.
Natalia Ramírez PedrazaDepartamento de Radiología, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Bethsabel Rodríguez EncinasDepartamento de Radiología, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Carolina Isabel Pérez CarriónDepartamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
María Isabel Jasso ÁvilaDepartamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Jorge Carlos Valladares-GarcíaDepartamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Pablo Esteban Vanegas-CedilloDepartamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Diana Hernández JuárezDepartamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Arsenio Vargas-VázquezFacultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Neftali Eduardo Antonio-VillaFacultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Paloma Almeda-ValdesUnidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Osbaldo Resendis-AntonioCentro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Marcia HiriartInstituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Alejandro FrankCentro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Carlos A Aguilar-SalinasUnidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, Mexico.
Ana Leonor RiveraCentro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversidad Nacional Autónoma de México · MXUniversidad Autónoma de la Ciudad de México · MXInstituto Nacional de Pediatria · MXNational College · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human body is a complex system maintained in homeostasis thanks to the interactions between multiple physiological regulation systems. When faced with physical or biological perturbations, this system must react by keeping a balance between adaptability and robustness. The SARS-COV-2 virus infection poses an immune system challenge that tests the organism's homeostatic response. Notably, the elderly and men are particularly vulnerable to severe disease, poor outcomes, and death. Mexico seems to have more infected young men than anywhere else. The goal of this study is to determine the differences in the relationships that link physiological variables that characterize the elderly and men, and those that characterize fatal outcomes in young men. To accomplish this, we examined a database of patients with moderate to severe COVID-19 (471 men and 277 women) registered at the "Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán" in March 2020. The sample was stratified by outcome, age, and sex. Physiological networks were built using 67 physiological variables (vital signs, anthropometric, hematic, biochemical, and tomographic variables) recorded upon hospital admission. Individual variables and system behavior were examined by descriptive statistics, differences between groups, principal component analysis, and network analysis. We show how topological network properties, particularly clustering coefficient, become disrupted in disease. Finally, anthropometric, metabolic, inflammatory, and pulmonary cluster interaction characterize the deceased young male group.

Indexed as

homeostasisnetwork physiologypro-inflammatory statesevere COVID-19sex differences

Identifiers

PMID35360235
PMCPMC8961032
OpenAlexW4220827828

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.